Insulet (PODD) EPS (Basic) Growth (3y) (2013 - 2026)
Insulet (PODD) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 17.98% |
| 10 | Insulet | 10.34 Bn | 9.81 Bn | 562.60 Mn | 51.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.86% |
| Mar 31, 2026 | 56.13% |
| Dec 31, 2025 | 80.69% |
| Sep 30, 2025 | 165.04% |
| Jun 30, 2025 | 38.09% |
| Mar 31, 2025 | 7.96% |
| Dec 31, 2024 | 49.35% |
| Sep 30, 2024 | 82.12% |
| Jun 30, 2024 | 109.40% |
| Dec 31, 2023 | 96.71% |
| Sep 30, 2023 | 61.48% |
| Jun 30, 2023 | 20.50% |
| Mar 31, 2023 | 130.47% |
| Dec 31, 2022 | 43.74% |
| Sep 30, 2022 | -97.36% |
| Jun 30, 2022 | -186.72% |
| Mar 31, 2022 | 75.60% |
| Dec 31, 2021 | 36.87% |
| Sep 30, 2021 | 86.71% |
| Jun 30, 2021 | -135.38% |